PERRI, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 247
EU - Europa 242
AS - Asia 50
AF - Africa 5
SA - Sud America 1
Totale 545
Nazione #
US - Stati Uniti d'America 243
IT - Italia 140
SE - Svezia 56
CN - Cina 19
IN - India 19
BG - Bulgaria 8
DE - Germania 8
SG - Singapore 8
FI - Finlandia 6
GB - Regno Unito 5
IE - Irlanda 5
RO - Romania 5
CA - Canada 4
MY - Malesia 3
TG - Togo 3
MK - Macedonia 2
SC - Seychelles 2
UA - Ucraina 2
AR - Argentina 1
BE - Belgio 1
FR - Francia 1
PL - Polonia 1
RS - Serbia 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
Totale 545
Città #
Rome 55
Chandler 42
Ashburn 25
Fairfield 21
Milan 13
San Paolo di Civitate 11
New York 9
Princeton 9
Woodbridge 9
Lawrence 8
Seattle 8
Sofia 8
Wilmington 8
Houston 6
Millbury 6
Dublin 5
Ann Arbor 4
Beijing 4
Cambridge 4
Helsinki 4
London 4
Porto Recanati 4
San Diego 4
San Mateo 4
Chapel Hill 3
Delhi 3
Fremont 3
Hebei 3
Lomé 3
Naples 3
Padova 3
Shanghai 3
Toronto 3
Andover 2
Boardman 2
Bologna 2
Boston 2
Floridia 2
Fuzhou 2
Guangzhou 2
Lappeenranta 2
Mahé 2
Singapore 2
Beograd 1
Brussels 1
Bühl 1
Caserta 1
Cecina 1
Colle Di Val D'elsa 1
Federal 1
Genova 1
Grafing 1
Grossostheim 1
Hangzhou 1
Hyderabad 1
Kilburn 1
Latina 1
Mountain View 1
New Delhi 1
Norwalk 1
Nuremberg 1
Ottawa 1
Redwood City 1
Riyadh 1
Sabaudia 1
Sacramento 1
Teramo 1
Thalmassing 1
Treviso 1
Varese 1
Totale 349
Nome #
JCPyV NCCR analysis in PML patients with different risk factors: Exploring common rearrangements as essential changes for neuropathogenesis 67
Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: A three-year observational cohort study 64
X Seminar- PhD day. Science for Democracy- Democracy for Science. PhD day Infectious Diseases, Microbiology and Public Health. Istituto Superiore di Sanità. 60
Increased sCD163 and sCD14 plasmatic levels and depletion of peripheral blood pro-inflammatory monocytes, myeloid and plasmacytoid dendritic cells in patients with severe COVID-19 pneumonia 59
Early IgG / IgA response in hospitalized COVID-19 patients is associated with a less severe disease 59
Real-life use of tocilizumab with or without corticosteroid in hospitalized patients with moderate-to-severe COVID-19 pneumonia. A retrospective cohort study 59
Chest computed tomography score, cycle threshold values and secondary infection in predicting COVID-19 mortality 58
Major reduction of NKT cells in patients with severe COVID-19 pneumonia 56
The peripheral blood immune cell profile in a teriflunomide-treated multiple sclerosis patient with COVID-19 pneumonia 54
Multiple sclerosis-disease modifying therapies affect humoral and T-cell response to mRNA COVID-19 vaccine 33
Evaluation of BAFF, APRIL and CD40L in ocrelizumab-treated pwMS and infectious risk 19
Totale 588
Categoria #
all - tutte 1.861
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.861


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202015 0 0 0 0 0 0 0 0 3 6 3 3
2020/202159 3 10 0 2 1 12 1 5 5 9 3 8
2021/2022183 4 2 27 15 20 10 27 13 15 5 36 9
2022/2023199 22 38 23 14 17 22 11 20 18 0 10 4
2023/2024132 5 10 3 27 18 28 3 21 1 16 0 0
Totale 588